Prosecution Insights
Last updated: October 01, 2026
Application No. 18/682,664

USE OF SUBSTITUTED CYCLOPENTENONES AND CYCLOPENTANONES AS AROMA INGREDIENTS

Non-Final OA §102§112
Filed
Feb 09, 2024
Priority
Aug 13, 2021 — EU 21191294.4 +1 more
Examiner
WHITELEY, JESSICA
Art Unit
Tech Center
Assignee
BASF SE
OA Round
1 (Non-Final)
89%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 89% — above average
89%
Career Allowance Rate
1359 granted / 1533 resolved
+28.6% vs TC avg
Moderate +7% lift
Without
With
+7.0%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 11m
Avg Prosecution
30 currently pending
Career history
1560
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
33.4%
-6.6% vs TC avg
§102
34.0%
-6.0% vs TC avg
§112
18.4%
-21.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1533 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claims 21 and 22 are objected to because of the following informalities: Both claims recite the structure of Formula (I) and state “compound of formula(I)” wherein it is believed applicant meant to have a space between “formula” and “(I)”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 21 and 25 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 22-24 and 26-37 depend on the above claims and, therefore, are also rejected. With regards to claim 21, the claim provides for a method for imparting an aroma but does not include any steps for the method, but, since the claims do not set forth any steps involved in the method/process, it is unclear what method/process applicant is intending to encompass. A claim is indefinite where it merely recites a method without any active, positive steps delimiting how this use is actually practiced. With regards to claim 25, the preamble of the claim states “The u method se according to claim 22”, it is unclear what is meant to be the preamble. For purposes of compact prosecution, it will be interpreted to be the method of claim 22. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 21, 23-24, and 30-37 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Scognamiglio et al (3/16/2012, Food and Chemical Toxicology, 50, S641-S645). With regards to claims 21 and 23-24, Scognamiglio teaches a fragrance material including the following compound: PNG media_image1.png 149 314 media_image1.png Greyscale (page 5642). With regards to claim 30, Scognamiglio teaches the fragrance ingredient to be used in a fragrance mixture (reading on composition) (page S641). With regards to claims 31 and 37, Scognamiglio teaches the fragrance mixture to be used in decorative cosmetics, fine fragrances, shampoos, toilet soaps, and other toiletries (page S641). With regards to claim 32, Scognamiglio teaches the compound to have a jasmin-like odor (page S641). With regards to claims 33 and 35, Scognamiglio teaches the amount of compound in the mixture to be 10% or 20% (page S643) With regards to claims 34 and 36, Scognamiglio teaches the compound to be put in corn oil (page S643) Claims 22, 24, and 38-39 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Minai (US 4,970,345). With regards to claims 21, 22, and 24, Minai teaches a cyclopentene having the following structure: PNG media_image2.png 70 99 media_image2.png Greyscale (abstract) wherein PNG media_image3.png 69 258 media_image3.png Greyscale (abstract). Manai is silent on the compound being used in a fragrance composition. However, However, when the structure recited in the reference is substantially identical to that of the claims, the claimed properties or function are presumed inherent. MPEP 2112.01. Because the prior art exemplifies Applicant’s claimed structure is used, the claimed physical properties relating to the scent of the compound are inherently present in the prior art. Absent an objective showing to the contrary, the addition of the claimed physical properties to the claim language fails to provide patentable distinction over the prior art. With regards to claims 38-39, Manai teaches the following compound: PNG media_image2.png 70 99 media_image2.png Greyscale (abstract) wherein PNG media_image3.png 69 258 media_image3.png Greyscale (abstract). Claims 21, 23, 28, and 38 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hennion et al (4/19/1951, Chemical Laboratories of the University of Notre Dame, 1289-1296). With regards to claims 21, 23, 28, and 38, Hennion teaches the following compound: PNG media_image4.png 116 197 media_image4.png Greyscale (page 1289) or PNG media_image5.png 120 144 media_image5.png Greyscale (page 1289). Hennion is silent on the compound being used in a fragrance composition. However, However, when the structure recited in the reference is substantially identical to that of the claims, the claimed properties or function are presumed inherent. MPEP 2112.01. Because the prior art exemplifies Applicant’s claimed structure is used, the claimed physical properties relating to the scent of the compound are inherently present in the prior art. Absent an objective showing to the contrary, the addition of the claimed physical properties to the claim language fails to provide patentable distinction over the prior art. Allowable Subject Matter Claims 25-27, 29, and 40 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The art does not teach the claimed compounds of the above claims with the specific limitations. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA WHITELEY whose telephone number is (571)272-5203. The examiner can normally be reached 8 - 5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 5712721130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA WHITELEY/Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Feb 09, 2024
Application Filed
Sep 04, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12748349
PHOTOSENSITIVE RESIN COMPOSITION AND DISPLAY DEVICE INCLUDING THE SAME
3y 10m to grant Granted Sep 29, 2026
Patent 12747363
ACTIVE ENERGY RAY-CURABLE INKJET INK COMPOSITION
3y 4m to grant Granted Sep 29, 2026
Patent 12741414
PARTICULATE BUILD MATERIALS FOR THREE-DIMENSIONAL PRINTING
3y 6m to grant Granted Sep 22, 2026
Patent 12735380
SYNTHESIS OF PARA-ALKYLATED SYRINGYL (METH)ACRYLATE DERIVATIVES AND PHOTOPOLYMERIZABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING IN DENTAL APPLICATIONS
3y 8m to grant Granted Sep 15, 2026
Patent 12735381
CARDANOL-BASED REACTIVE DILUENTS AND THEIR USE AND PREPARATION
3y 0m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
89%
Grant Probability
96%
With Interview (+7.0%)
1y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1533 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month